Photo taken from ESMO/LinkedIn
Jun 29, 2024, 02:57
Komal Jhaveri on antibody-drug conjugates in metastatic breast cancer – ESMO
ESMO shared a post on LinkedIn:
“For European Society for Medical Oncology (ESMO) members: Breaking Science in Breast Cancer.
Komal Jhaveri talks about the efficacy and safety of antibody-drug conjugates in metastatic breast cancer.
Don’t miss this video and others from the series on OncologyPRO.
Additional information.
Source: ESMO/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 3, 2025, 15:13
Aug 3, 2025, 14:58
Aug 3, 2025, 14:54
Aug 3, 2025, 14:23
Aug 3, 2025, 14:21